Oncology
Scott Schuetze, MD, PHD
Clinical Professor, Department of Internal Medicine, University of Michigan Medical School; Director, Connective Tissue Oncology Program, Rogel Cancer Center; Medical Co-Director, Oncology Clinical Trials Support Unit
Dr. Scott M. Schuetze, MD, PhD, is a medical oncologist specializing in connective tissue tumors, including soft tissue and bone sarcomas, as well as benign connective tissue tumors. With over 25 years of experience, he provides care to adult patients with these rare malignancies at the University of Michigan Rogel Cancer Center in Ann Arbor, MI. His clinical practice emphasizes experimental therapeutic drugs, imaging and blood-based biomarkers for monitoring disease, and molecular pathogenesis
30+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (American Board of Internal Medicine)
Education & Training
- Oregon Health and Science University School of Medicine — MD, PhD (Biochemistry and Molecular Biology), 1993
- University of Washington/Fred Hutchinson Cancer Research Center — Fellowship, Hematology and Medical Oncology, 1996-1999
- Duke University Hospital — Residency, Internal Medicine, 1993-1996
- Rice University — BA
Peer Recognition
- ASCO — Advanced Clinical Research Award in Sarcoma
2008
- NIH — Cancer Clinical Investigator Team Leadership Award
2012
- University of Michigan Division of Hematology/Oncology — Excellence in Research Award
2010
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Rogel Cancer Center
- University of Michigan Medical Center
- Michigan Medicine Pulmonary Clinic, Taubman Center
Languages
English
Experience
30+ years in practice